Understanding aberrant white matter development in schizophrenia: an avenue for therapy?

References

• Kanaan R, Kim J, Kaufmann W, Pearlson G, Barker G, Mcguire P. Diffusion tensor imaging in schizophrenia. Biol. Psychiatry58(12), 921–929 (2005).
   PubMed Web of Science ®Google Scholar
• Kubicki M, Mccarley R, Westin CF et al. A review of diffusion tensor imaging studies in schizophrenia. J. Psychiatr. Res.41(1–2), 15–30 (2007).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Wood S, Velakoulis D, Pantelis C. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci. Biobehav. Rev.30, 918–948 (2006).
   PubMed Web of Science ®Google Scholar
• Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin. Neurosci.12(3), 317–332 (2010).
   PubMedGoogle Scholar
• Walterfang M, Wood S, Velakoulis D, Copolov D, Pantelis C. Diseases of white matter and schizophrenia-like psychosis. Aust. NZ J. Psychiatry39, 746–756 (2005).
   PubMed Web of Science ®Google Scholar
• Friston K. Schizophrenia and the disconnection hypothesis. Acta Psychiatrica Scand. Suppl.99, 68–79 (1999).
   Google Scholar
• Friston K. The disconnection hypothesis. Schizophr. Res.30, 115–125 (1998).
   PubMed Web of Science ®Google Scholar
• Wernicke C. [Outline of Psychiatry. 2nd Edition]. Thieme, Leipzig (1906).
   Google Scholar
• Pantelis C, Barnes T, Nelson H. Is the concept of frontal-subcortical dementia relevant to schizophrenia? Br. J. Psychiatry160, 442–460 (1992).
   PubMed Web of Science ®Google Scholar
• Andreasen N, Paradiso S, O’leary D. ‘Cognitive dysmetria’ as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr. Bull.24, 203–218 (1998).
   PubMed Web of Science ®Google Scholar
• Crow T. Schizophrenia as a transcallosal misconnection syndrome. Schizophr. Res.30, 111–114 (1998).
   PubMed Web of Science ®Google Scholar
• Schoenemann P, Sheehan M, Glotzer L. Prefrontal white matter volume is disproportionately larger in humans than in other primates. Nature Neurosci.8, 242–252 (2005).
   PubMed Web of Science ®Google Scholar
• Nolte N. The Human Brain. Mosby, MO, USA (1999).
   Google Scholar
• Byrd S, Darling C, Wilczynski M. White matter of the brain: maturation and myelination of magnetic resonance in infants and children. Neuroimag. Clin. N. Am.3, 247–266 (1993).
   Google Scholar
• Yakovlev P, Lecours A. The myelogenetic cycles of regional maturation of the brain. In: Regional Development of the Brain in Early Life. Minkowski A (Ed.). FA Davis, PA, USA, 3–70 (1967).
   Google Scholar
• Webb SJ, Monk CS, Nelson CA. Mechanisms of postnatal neurobiological development: implications for human development. Dev. Neuropsychol.19(2), 147–171 (2001).
   PubMed Web of Science ®Google Scholar
• Barkovich AJ. Concepts of myelin and myelination in neuroradiology. AJNR Am. J. Neuroradiol.21(6), 1099–1109 (2000).
   PubMed Web of Science ®Google Scholar
• Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology166(1 Pt 1), 173–180 (1988).
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Beckson M, Lu P, Nuechterlein K, Edwards N, Mintz J. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch. Gen. Psychiatr.58, 461–465 (2001).
   PubMed Web of Science ®Google Scholar
• Benes F, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatr.51, 477–484 (1994).
   PubMed Web of Science ®Google Scholar
• Lim K, Zipursky R, Watts M, Pfefferbaum A. Decreased gray matter in normal aging: an in vivo magnetic resonance study. J. Gerontol.47, B26–B30 (1992).
   Google Scholar
• Pfefferbaum A, Mathalon D, Sullivan E, Al E. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch. Neurol.51, 874–887 (1994).
   PubMed Web of Science ®Google Scholar
• O’kusky J, Colonnier M. Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: a stereological analysis in normal and monocularly deprived animals. J. Comp. Neurol.210(3), 307–315 (1982).
   PubMed Web of Science ®Google Scholar
• Elvidge A, Reed G. Biopsy studies of cerebral pathologic changes in schizophrenia and manic-depressive psychosis. Arch. Neurol. Psychiatry40, 227–268 (1938).
   Google Scholar
• Uranova N, Orlovskaya D, Vikhreva O et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull.55, 597–610 (2001).
   PubMed Web of Science ®Google Scholar
• Uranova N, Orlovskaya D. Ultrastructural pathology of neuronal connectivity in postmortem brains of schizophrenic patients. Ann. Psychiatr.6, 55–72 (1996).
   Google Scholar
• Uranova N, Casanova M, Devaughn N, Orlovskaya D, Denisov D. Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients (letter). Schizophr. Res.22, 81–83 (1996).
   PubMed Web of Science ®Google Scholar
• Orlovskaya D, Vostrikov V, Rachmanova V, Uranova N. Decreased numerical density of oligodendroglial cells in post-mortem prefrontal cortex in schizophrenia, bipolar affective disorder, and major depression (abstr). Schizophr. Res.41, 105–106 (2000).
   Web of Science ®Google Scholar
• Orlovskaya D, Denisov D, Uranova N. The ultrastructural pathology of myelinated fibers and oligodendroglial cells in autopsied caudate nucleus of schizophrenics. Schizophr. Res.24, 39–40 (1997).
   Google Scholar
• Orlovskaya D, Vikhreva O, Zimina I, Denisov D, Uranova N. Ultrastructural dystrophic changes of oligodendroglial cells in autopsied prefrontal cortex and striatum in schizophrenia: a morphometric study. Schizophr. Res.36, 82–83 (1999).
   Google Scholar
• Hof P, Haroutunian V, Friedrich VJ et al. Loss and altered spatial distrubition of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry53, 1075–1085 (2003).
   PubMed Web of Science ®Google Scholar
• Hof P, Haroutunian V, Copland C, Al E. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res.27, 1193–1200 (2002).
   PubMed Web of Science ®Google Scholar
• Kim S, Webster MJ. Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry16(4), 452–461 (2010).
   PubMed Web of Science ®Google Scholar
• Kim S, Webster MJ. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry15(3), 326–336 (2010).
   PubMed Web of Science ®Google Scholar
• Ewald H, Flint TJ, Jorgensen TH et al. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am. J. Med. Genet.114(2), 196–204 (2002).
   PubMed Web of Science ®Google Scholar
• Farkas N, Lendeckel U, Dobrowolny H et al. Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J. Biol. Psychiatry11(3), 556–566 (2010).
   PubMed Web of Science ®Google Scholar
• Gregg JR, Herring NR, Naydenov AV, Hanlin RP, Konradi C. Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Schizophr. Res.113(2–3), 277–287 (2009).
   PubMed Web of Science ®Google Scholar
• Mcdonald J, Althomsons S, Choi D, Goldberg M. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor mediated excitotoxicity. Nat. Med.4, 291–297 (1998).
   PubMed Web of Science ®Google Scholar
• Farber N, Wozniak D, Price M, Al E. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol. Psychiatry38, 788–796 (1995).
   PubMed Web of Science ®Google Scholar
• Rees S, Inder T. Fetal and neonatal origins of altered brain development. Early Hum. Dev.81, 753–761 (2005).
   PubMed Web of Science ®Google Scholar
• Bergles DE, Roberts JD, Somogyi P, Jahr CE. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature405(6783), 187–191 (2000).
   PubMed Web of Science ®Google Scholar
• Livni E, Munitz H, Tyano S et al. Further studies on cell-mediated immunity to myelin basic protein in schizophrenic patients. J. Neurol. Sci.42, 437–440 (1979).
   PubMedGoogle Scholar
• Kuritzky A, Livni E, Munitz H et al. Cell-mediated immunity to human myelin basic protein in schizophrenic patients. J. Neurol. Sci.30, 369–373 (1976).
   PubMed Web of Science ®Google Scholar
• Rimon R, Ahokas A, Ruutianen J, Halonen P. Myelin basic protein antibodies in catatonic schizophrenia. J. Clin. Psychiatry47, 26–28 (1986).
   PubMed Web of Science ®Google Scholar
• Schmitt A, Wilczek K, Blennow K et al. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol. Psychiatry56, 41–45 (2004).
   PubMed Web of Science ®Google Scholar
• Hennah W, Varilo T, Paunio T, Peltonen L. Haplotype analysis and identification of genes for a complex trait: examples from schizophrenia. Ann. Med.36, 322–331 (2003).
   Web of Science ®Google Scholar
• Novak G, Kim D, Seeman P, Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Mol. Brain Res.107, 183–189 (2002).
   PubMedGoogle Scholar
• Covault J, Lee J, Jensen K, Kranzler H. Nogo 3´ untranslated region CAA insertion: failure to replicate association with schizophrenia and demonstration of marked population difference in the frequency of the insertion. Mol. Brain Res.120, 197–200 (2004).
   PubMedGoogle Scholar
• Xiong L, Rouleau G, Delisi L et al. CAA insertion polymorphism in the 3´UTR of Nogo gene on 2p14 is not associated with schizophrenia. Mol. Brain Res.133, 153–156 (2005).
   PubMedGoogle Scholar
• Gregorio S, Mury F, Ojopi E et al. Nogo CAA 3´UTR insertion polymorphism is not associated with schizophrenia nor with bipolar disorder. Schizophr. Res.75, 5–9 (2005).
   PubMed Web of Science ®Google Scholar
• Tan E-C, Chong S-A, Wang H, Lim E-P, Teo Y-Y. Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. Mol. Brain Res.139(2), 212–216 (2005).
   PubMedGoogle Scholar
• Sinibaldi L, De Luca A, Bellacchio E et al. Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum. Mutat.24, 534–535 (2004).
   PubMedGoogle Scholar
• Budel S, Padukkavidana T, Liu BP et al. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci.28(49), 13161–13172 (2008).
   PubMed Web of Science ®Google Scholar
• Hsu R, Woodroffe A, Lai WS et al. Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS One2(11), e1234 (2007).
   PubMed Web of Science ®Google Scholar
• Willi R, Weinmann O, Winter C et al. Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J. Neurosci.30(2), 556–567 (2010).
   PubMed Web of Science ®Google Scholar
• Willi R, Aloy EM, Yee BK, Feldon J, Schwab ME. Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A. Genes Brain Behav.8(2), 181–192 (2009).
   PubMed Web of Science ®Google Scholar
• Wan C, Yang Y, Feng G et al. Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci. Lett.388, 126–131 (2005).
   PubMed Web of Science ®Google Scholar
• Yang Y, Qin W, Shugart Y et al. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr. Res.75, 11–19 (2005).
   PubMed Web of Science ®Google Scholar
• Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron39(1), 13–25 (2003).
   PubMed Web of Science ®Google Scholar
• Sauvageot CM, Stiles CD. Molecular mechanisms controlling cortical gliogenesis. Curr. Opin. Neurobiol.12(3), 244–249 (2002).
   PubMed Web of Science ®Google Scholar
• Georgieva L, Moskvina V, Peirce T et al. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl Acad. Sci. USA103(33), 12469–12474 (2006).
   PubMed Web of Science ®Google Scholar
• Huang K, Tang W, Tang R et al. Positive association between OLIG2 and schizophrenia in the Chinese Han population. Hum. Genet.122(6), 659–660 (2008).
   PubMed Web of Science ®Google Scholar
• Usui H, Takahashi N, Saito S et al. The 2´,3´-cyclic nucleotide 3´-phosphodiesterase and oligodendrocyte lineage transcription factor 2 genes do not appear to be associated with schizophrenia in the Japanese population. Schizophr. Res.88(1–3), 245–250 (2006).
   PubMed Web of Science ®Google Scholar
• Qin W, Gao J, Xing Q et al. A family-based association study of PLP1 and schizophrenia. Neurosci. Lett.375, 207–210 (2005).
   PubMed Web of Science ®Google Scholar
• Peirce TR, Bray NJ, Williams NM et al. Convergent evidence for 2´,3´-cyclic nucleotide 3´-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry63(1), 18–24 (2006).
   PubMed Web of Science ®Google Scholar
• Hakak Y, Walker J, Li C et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA98, 4746–4751 (2001).
   PubMed Web of Science ®Google Scholar
• Copland C, Dracheva S, Davis K, Haroutunian V. mRNA expression of three isoforms of myelin associated glycoprotein (MAG) in patients with schizophrenia [abstract]. Abstr. Soc. Neurosci.28, 494 (2002).
   Google Scholar
• Tkachev D, Mimmack M, Ryan M et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet362, 798–805 (2003).
   PubMed Web of Science ®Google Scholar
• Sugai T, Kawamura M, Iritani S et al. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann. NY Acad. Sci.1025, 84–91 (2004).
   PubMed Web of Science ®Google Scholar
• Paulson L, Martin P, Persson A, Al E. Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J. Neurosci. Res.15, 526–533 (2003).
   Google Scholar
• Mitkus SN, Hyde TM, Vakkalanka R et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr. Res.98(1–3), 129–138 (2008).
   PubMed Web of Science ®Google Scholar
• Aston C, Jiang L, Sokolov B. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J. Neurosci. Res.77, 858–866 (2004).
   PubMed Web of Science ®Google Scholar
• Katsel P, Davis K, Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr. Res.79(2–3), 157–173 (2005).
   PubMed Web of Science ®Google Scholar
• Paez P, Marta C, Moreno M, Soto E, Pasquini J. Apotransferrin decreases migration and enhances differentiation of oligodendroglial progenitor cells in an in-vitro system. Dev. Neurosci.24, 47–58 (2002).
   PubMed Web of Science ®Google Scholar
• Woo T, Crowell A. Targeting synapses and myelin in the prevention of schizophrenia. Schizophr. Res.73, 193–207 (2005).
   PubMed Web of Science ®Google Scholar
• Mccullumsmith RE, Gupta D, Beneyto M et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res.90(1–3), 15–27 (2007).
   PubMed Web of Science ®Google Scholar
• Dracheva S, Davis K, Chin B, Woo D, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurol. Dis.21(3), 531–540 (2005).
   PubMed Web of Science ®Google Scholar
• Byne W, Dracheva S, Chin B, Schmeidler JM, Davis KL, Haroutunian V. Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei. Schizophr. Res.98(1–3), 118–128 (2008).
   PubMed Web of Science ®Google Scholar
• Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int. J. Neuropsychopharmacol.10(4), 565–573 (2007).
   PubMed Web of Science ®Google Scholar
• Parlapani E, Schmitt A, Erdmann A et al. Association between myelin basic protein expression and left entorhinal cortex pre-α cell layer disorganization in schizophrenia. Brain Res.1301, 126–134 (2009).
   PubMed Web of Science ®Google Scholar
• Novak G, Tallerico T. Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3´-UTR. Brain Res.1120(1), 161–171 (2006).
   PubMed Web of Science ®Google Scholar
• Haroutunian V, Katsel P, Dracheva S, Davis KL. The human homolog of the QKI gene affected in the severe dysmyelination ‘quaking’ mouse phenotype: downregulated in multiple brain regions in schizophrenia. Am. J. Psychiatry163(10), 1834–1837 (2006).
   PubMed Web of Science ®Google Scholar
• Katsel P, Davis KL, Li C et al. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology33(12), 2993–3009 (2008).
   PubMed Web of Science ®Google Scholar
• Aberg K, Saetre P, Jareborg N, Jazin E. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc. Natl Acad. Sci. USA103(19), 7482–7487 (2006).
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Folsom TD, Reutiman TJ et al. Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice. Schizophr. Res.112(1–3), 46–53 (2009).
   PubMed Web of Science ®Google Scholar
• Fatemi S, Reutiman T, Folsom T et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res.99, 56–70 (2008).
   PubMed Web of Science ®Google Scholar
• Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med. Genomics2, 28 (2009).
   PubMedGoogle Scholar
• Sokolov BP. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int. J. Neuropsychopharmacol.10(4), 547–555 (2007).
   PubMed Web of Science ®Google Scholar
• Wright I, Rabe-Hesketh S, Woodruff P, David A, Murray R, Bullmore E. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry157, 16–25 (2000).
   PubMed Web of Science ®Google Scholar
• Cannon T, Van Erp T, Huttunen M et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry55, 1084–1091 (1998).
   PubMed Web of Science ®Google Scholar
• Hulshoff Pol H, Brans R, Van Haren N et al. Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia. Biol. Psychiatry55, 126–130 (2004).
   PubMed Web of Science ®Google Scholar
• Bose SK, Mackinnon T, Mehta MA et al. The effect of ageing on grey and white matter reductions in schizophrenia. Schizophr. Res.112(1–3), 7–13 (2009).
   PubMed Web of Science ®Google Scholar
• Tanskanen P, Haapea M, Veijola J et al. Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis. Psychiatry Res.174(2), 116–120 (2009).
   PubMed Web of Science ®Google Scholar
• Buchanan R, Vladar K, Barta P, Pearlson G. Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry155, 1049–1055 (1998).
   PubMed Web of Science ®Google Scholar
• Sanfilipo M, Lafargue T, Rusinek H et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatr.57, 471–480 (2000).
   PubMed Web of Science ®Google Scholar
• Sigmundsson T, Suckling J, Maier M, Al E. Structural abnormalities in frontal, temporal and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am. J. Psychiatry158, 234–243 (2001).
   PubMed Web of Science ®Google Scholar
• Breir A, Buchanan R, Elkashef A, Munson R, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatr.49, 921–926 (1992).
   PubMed Web of Science ®Google Scholar
• Hulshoff Pol H, Schnack H, Bertens M et al. Volume changes in gray matter in patients with schizophrenia. Am. J. Psychiatry159, 244–250 (2002).
   PubMed Web of Science ®Google Scholar
• Wible C, Anderson J, Shenton M et al. Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study. Psychiatr. Res.108, 65–78 (2001).
   PubMed Web of Science ®Google Scholar
• Paillere-Martinot M, Caclin A, Artiges E et al. Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr. Res.50, 19–26 (2001).
   PubMed Web of Science ®Google Scholar
• Mathalon D, Pfefferbaum A, Lim K, Rosenbloom M, Sullivan E. Compounded brain volume deficits in schizophrenia-alcoholism morbidity. Arch. Gen. Psychiatry60, 245–252 (2003).
   PubMed Web of Science ®Google Scholar
• Ho B, Andreasen N, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry60, 585–594 (2003).
   PubMed Web of Science ®Google Scholar
• Arango C, Breier A, Mcmahon R, Carpenter W, Buchanan R. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal and caudate brain volumes. Am. J. Psychiatry160, 1421–1427 (2003).
   PubMed Web of Science ®Google Scholar
• Okugawa G, Sedvallo G, Agartz I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci.252, 120–123 (2002).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Suzuki M, Kawasaki Y, Al E. Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry53, 593–600 (2003).
   PubMed Web of Science ®Google Scholar
• Mitelman S, Shihabuddin L, Brickman A, Hazlett E, Buchsbaum M. MRI assessment of gray and white matter distribution in Brodmann’s areas of the cortex in pattients with schizophrenia with good and poor outcomes. Am. J. Psychiatry160, 2154–2168 (2003).
   PubMed Web of Science ®Google Scholar
• Davies D, Wardell A, Woolsey R, James A. Enlargement of the fornix in early onset schizophrenia: a quantitative MRI study. Neurosci. Lett.301, 163–166 (2001).
   PubMed Web of Science ®Google Scholar
• Nieuwenhuys R, Voogd J, Van Huijzen C. The Human Central Nervous System. Springer-Verlag, Berlin, Germany (1988).
   Google Scholar
• Zhou S, Suzuki M, Hagino H et al. Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia. Biol. Psychiatry54(4), 427–436 (2003).
   PubMed Web of Science ®Google Scholar
• Goghari VM, Lang DJ, Khorram B et al. Anterior internal capsule volumes increase in patients with schizophrenia switched from typical antipsychotics to olanzapine. J. Psychopharmacol.25(5), 621–629 (2010).
   PubMed Web of Science ®Google Scholar
• Lang DJ, Khorram B, Goghari VM et al. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr. Res.87(1–3), 89–99 (2006).
   PubMed Web of Science ®Google Scholar
• Brickman AM, Buchsbaum MS, Ivanov Z et al. Internal capsule size in good-outcome and poor-outcome schizophrenia. J. Neuropsychiatry Clin. Neurosci.18(3), 364–376 (2006).
   PubMed Web of Science ®Google Scholar
• Wobrock T, Gruber O, Schneider-Axmann T et al. Internal capsule size associated with outcome in first-episode schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci.259(5), 278–283 (2009).
   PubMed Web of Science ®Google Scholar
• Dequardo J, Keshavan M, Bookstein F, Al E. Landmark-based morphometric analysis of first-episode schizophrenia. Biol. Psychiatry45, 1321–1328 (1999).
   PubMed Web of Science ®Google Scholar
• Downhill J, Buchsbaum M, Wei T, Al E. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr. Res.42, 193–208 (2000).
   PubMed Web of Science ®Google Scholar
• Frumin M, Golland P, Kikinis R et al. Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am. J. Psychiatry159, 866–868 (2002).
   PubMed Web of Science ®Google Scholar
• Narr KL, Thompson PM, Sharma T, Moussai J, Cannestra AF, Toga AW. Mapping morphology of the corpus callosum in schizophrenia. Cereb. Cortex10(1), 40–49 (2000).
   PubMed Web of Science ®Google Scholar
• Mitelman SA, Nikiforova YK, Canfield EL et al. A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophr. Res.114(1–3), 144–153 (2009).
   PubMed Web of Science ®Google Scholar
• Narr KL, Cannon TD, Woods RP et al. Genetic contributions to altered callosal morphology in schizophrenia. J. Neurosci.22(9), 3720–3729 (2002).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Wood AG, Reutens DC et al. Morphology of the corpus callosum at different stages of schizophrenia: cross-sectional study in first-episode and chronic illness. Br. J. Psychiatry192(6), 429–434 (2008).
   PubMed Web of Science ®Google Scholar
• Arnone D, Mcintosh A, Tan G, Ebmeier K. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophr. Res.101, 124–132 (2008).
   PubMed Web of Science ®Google Scholar
• Rotarska-Jagiela A, Schonmeyer R, Oertel V, Haenschel C, Vogeley K, Linden DE. The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions. Neuroimage39(4), 1522–1532 (2008).
   PubMed Web of Science ®Google Scholar
• Seok JH, Park HJ, Chun JW et al. White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Psychiatry Res.156(2), 93–104 (2007).
   PubMed Web of Science ®Google Scholar
• Wolf RC, Hose A, Frasch K, Walter H, Vasic N. Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia. Eur. Psychiatry23(8), 541–548 (2008).
   PubMed Web of Science ®Google Scholar
• Diwadkar V, Dabellis M, Sweeney J, Pettegrew J, Keshavan M. Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophr. Res.67, 277–282 (2004).
   PubMed Web of Science ®Google Scholar
• Bachmann S, Pantel J, Flender A, Bottmer C, Essig M, Schroder J. Corpus callosum in first-episode patients with schizophrenia – a magnetic resonance imaging study. Psychol. Med.33, 1019–1027 (2003).
   PubMed Web of Science ®Google Scholar
• Keshavan M, Diwadkar V, Harenski K, Al E. Abnormalities of the corpus callosum in first episode treatment naive schizophrenia. J. Neurol. Neurosurg. Psychiatr.72, 757–760 (2002).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Wood AG, Barton S et al. Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives. Prog. Neuropsychopharmacol. Biol. Psychiatry33(6), 1050–1057 (2009).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Wood AG, Reutens DC et al. Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis. Psychiatry Res.173(1), 77–82 (2009).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Yung A, Wood AG et al. Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophr. Res.103(1–3), 1–10 (2008).
   PubMed Web of Science ®Google Scholar
• Woodruff P, Mcmanus I, David A. Meta-analysis of corpus callosum size in schizophrenia. J. Neurol. Neurosurg. Psychiatr.58, 457–461 (1995).
   PubMed Web of Science ®Google Scholar
• Meisenzahl E, Frodl T, Greiner J et al. Corpus callosum size in schizophrenia – a magnetic resonance imaging analysis. Eur. Arch. Psychiatry Clin. Neurosci.249, 305–312 (1999).
   PubMed Web of Science ®Google Scholar
• Pagsberg AK, Baare WF, Raabjerg Christensen AM et al. Structural brain abnormalities in early onset first-episode psychosis. J. Neural. Transm.114(4), 489–498 (2007).
   PubMed Web of Science ®Google Scholar
• Price G, Cercignani M, Bagary MS et al. A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr. Res.87(1–3), 100–108 (2006).
   PubMed Web of Science ®Google Scholar
• Spalletta G, Tomaiuolo F, Marino V, Bonaviri G, Trequattrini A, Caltagirone C. Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophr. Res.64, 15–23 (2003).
   PubMed Web of Science ®Google Scholar
• Whitford TJ, Grieve SM, Farrow TF et al. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am. J. Psychiatry164(7), 1082–1089 (2007).
   PubMed Web of Science ®Google Scholar
• Hulshoff Pol H, Schnack H, Mandl R et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage21, 27–35 (2004).
   PubMed Web of Science ®Google Scholar
• Mcintosh A, Job D, Moorhead T, Harrison L, Lawrie S, Johnstone E. White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives. Biol. Psychiatry58(3), 254–257 (2005).
   PubMed Web of Science ®Google Scholar
• Antonova E, Kumari V, Morris R, Halari R, Mehrotra R, Sharma T. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol. Psychiatry58, 457–467 (2005).
   PubMed Web of Science ®Google Scholar
• Walterfang M, Mcguire P, Yung A et al. White matter volume changes in people who develop psychosis. Br. J. Psychiatry193, 210–215 (2008).
   PubMed Web of Science ®Google Scholar
• Chan WY, Yang GL, Chia MY et al. White matter abnormalities in first-episode schizophrenia: a combined structural MRI and DTI study. Schizophr. Res.119(1–3), 52–60 (2010).
   PubMed Web of Science ®Google Scholar
• Chua SE, Cheung C, Cheung V et al. Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophr. Res.89(1–3), 12–21 (2007).
   PubMed Web of Science ®Google Scholar
• Tanskanen P, Ridler K, Murray GK et al. Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of Illness. Schizophr. Bull.36(4), 766–77 (2008).
   PubMed Web of Science ®Google Scholar
• Witthaus H, Brune M, Kaufmann C et al. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients. Schizophr. Res.102(1–3), 141–149 (2008).
   PubMed Web of Science ®Google Scholar
• Wible C, Shenton M, Hokama H et al. Prefrontal cortex and schizophrenia: a quantitative magnetic resonance imaging study. Arch. Gen. Psychiatr.52, 279–288 (1995).
   PubMed Web of Science ®Google Scholar
• Di X, Chan RC, Gong QY. White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry33(8), 1390–1394 (2009).
   PubMed Web of Science ®Google Scholar
• Dousset V, Grossman R, Ramer K et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology182, 483–491 (1992).
   PubMed Web of Science ®Google Scholar
• Dousset V, Brochet B, Vital A et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. Am. J. Neuroradiol.16, 225–231 (1995).
   PubMed Web of Science ®Google Scholar
• Van Waesberghe J, Kamphorst W, De Groot C et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol.46(5), 747–754 (1999).
   PubMed Web of Science ®Google Scholar
• Foong J, Maier M, Barker G, Brocklehurs S, Miller D, Ron M. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J. Neurol. Neurosurg. Psychiatr.68, 70–74 (2000).
   PubMed Web of Science ®Google Scholar
• Foong J, Symms M, Barker G, Al E. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain124, 882–892 (2001).
   PubMed Web of Science ®Google Scholar
• Bagary M, Symms M, Barker G, Mutsatsa S, Joyce E, Ron M. Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch. Gen. Psychiatry60, 779–788 (2003).
   PubMed Web of Science ®Google Scholar
• Price G, Cercignani M, Chu EM et al. Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. Neuroimage49(1), 185–192 (2010).
   PubMed Web of Science ®Google Scholar
• Kubicki M, Park H, Westin C et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage26, 1109–1118 (2005).
   PubMed Web of Science ®Google Scholar
• Mandl RC, Schnack HG, Luigjes J et al. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophr. Bull.36(4), 778–787 (2008).
   PubMed Web of Science ®Google Scholar
• Lim K, Hedehus M, Moseley M, De Crespigny A, Sullivan E, Pfefferbaum A. Compromised white matter integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatr.56, 367–374 (1999).
   PubMed Web of Science ®Google Scholar
• Steel R, Bastin M, Mcconnell S et al. Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (MRS) in schizophrenic subjects and normal controls. Psychiatr. Res.106, 161–170 (2001).
   PubMed Web of Science ®Google Scholar
• Hoptman M, Volavka J, Johnson G, Weiss E, Bilder R, Lim K. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol. Psychiatry52, 9–14 (2002).
   PubMed Web of Science ®Google Scholar
• Wolkin A, Choi C, Szilagyi S, Sanfilipo M, Rotrosen J, Lim K. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am. J. Psychiatry160, 572–574 (2003).
   PubMed Web of Science ®Google Scholar
• Minami T, Nobuhara K, Okugawa G, Al E. Diffusion tensor magnetic resonance imaging ot disruption of regional white matter in schizophrenia. Neuropsychobiol.47, 141–145 (2003).
   PubMed Web of Science ®Google Scholar
• Sun Z, Wang F, Cui L et al. Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study. Neuroreport14, 1833–1836 (2003).
   PubMed Web of Science ®Google Scholar
• Kumra S, Ashtari M, Mcmeniman M et al. Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biol. Psychiatry55, 1138–1145 (2004).
   PubMed Web of Science ®Google Scholar
• Kitamura H, Matsuzawa H, Shiori T, Someya T, Kwee I, Nakada T. Diffusion tensor analysis in chronic schizophrenia: a preliminary study on a high-field (3.0T) system. Eur. Arch. Psychiatry Clin. Neurosci.255(5), 313–318 (2005).
   PubMed Web of Science ®Google Scholar
• Shin YW, Kwon JS, Ha TH et al. Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. Neuroimage30(4), 1285–1291 (2006).
   PubMed Web of Science ®Google Scholar
• Rose SE, Chalk JB, Janke AL et al. Evidence of altered prefrontal-thalamic circuitry in schizophrenia: an optimized diffusion MRI study. Neuroimage32(1), 16–22 (2006).
   PubMed Web of Science ®Google Scholar
• Kuroki N, Kubicki M, Nestor PG et al. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol. Psychiatry60(1), 22–31 (2006).
   PubMed Web of Science ®Google Scholar
• Fitzsimmons J, Kubicki M, Smith K et al. Diffusion tractography of the fornix in schizophrenia. Schizophr. Res.107(1), 39–46 (2009).
   PubMed Web of Science ®Google Scholar
• Foong J, Maier M, Clark C, Barker G, Miller D, Ron M. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J. Neurol. Neurosurg. Psychiatr.68, 242–244 (2000).
   PubMed Web of Science ®Google Scholar
• Price G, Bagary M, Cercignani M, Altmann D, Ron M. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. J. Neurol. Neurosurg. Psychiatr.76, (2005).
   PubMedGoogle Scholar
• Brambilla P, Cerini R, Gasparini A et al. Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr. Res.79(2–3), 201–210 (2005).
   PubMed Web of Science ®Google Scholar
• Kanaan RA, Shergill SS, Barker GJ et al. Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Res.146(1), 73–82 (2006).
   PubMed Web of Science ®Google Scholar
• Kubicki M, Westin C, Nestor P et al. Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol. Psychiatry54, 1171–1180 (2003).
   PubMed Web of Science ®Google Scholar
• Wang F, Sun Z, Cui L et al. Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. Am. J. Psychiatry161, 573–575 (2004).
   PubMed Web of Science ®Google Scholar
• Nestor P, Kubicki M, Gurrera R et al. Neuropsychological correlates of diffusion tensor imaging in schizophrenia. Neuropsychology18, 629–637 (2004).
   PubMed Web of Science ®Google Scholar
• Jones D, Catani M, Pierpaoli C et al. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum. Brain Mapp.27(3), 230–238 (2005).
   Web of Science ®Google Scholar
• Takei K, Yamasue H, Abe O et al. Structural disruption of the dorsal cingulum bundle is associated with impaired Stroop performance in patients with schizophrenia. Schizophr. Res.114(1–3), 119–127 (2009).
   PubMed Web of Science ®Google Scholar
• Voineskos AN, Lobaugh NJ, Bouix S et al. Diffusion tensor tractography findings in schizophrenia across the adult lifespan. Brain133(Pt 5), 1494–1504 (2010).
   PubMed Web of Science ®Google Scholar
• Wang F, Sun Z, Du X et al. A diffusion tensor imaging study of middle and superior cerebellar peduncle in male patients with schizophrenia. Neurosci. Lett.348, 135–138 (2003).
   PubMed Web of Science ®Google Scholar
• Okugawa G, Nobuhara K, Minami T et al. Subtle disruption of the middle cerebellar peduncles in patients with schizophrenia. Neuropsychobiol.50, 119–123 (2004).
   PubMed Web of Science ®Google Scholar
• Okugawa G, Nobuhara K, Sugimoto T, Kinoshita T. Diffusion tensor imaging study of the middle cerebellar peduncle in patients with schizophrenia. Cerebellum4, 123–127 (2005).
   PubMed Web of Science ®Google Scholar
• Okugawa G, Nobuhara K, Minami T et al. Neural disorganization in the superior cerebellar peduncle and cognitive abnormality in patients with schizophrenia: a diffusion tensor imaging study. Prog. Neuropsychopharmacol. Biol. Psychiatry30(8), 1408–1412 (2006).
   PubMed Web of Science ®Google Scholar
• Hubl D, Koenig T, Strik W et al. Pathways that make voices: white matter changes in auditory hallucinations. Arch. Gen. Psychiatr.61, 658–668 (2004).
   PubMed Web of Science ®Google Scholar
• Kubicki M, Westin C, Maier S et al. Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am. J. Psychiatry159, 813–820 (2002).
   PubMed Web of Science ®Google Scholar
• Jones DK, Catani M, Pierpaoli C et al. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum. Brain Mapp.27(3), 230–238 (2006).
   PubMed Web of Science ®Google Scholar
• Karlsgodt KH, Van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon TD. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol. Psychiatry63(5), 512–518 (2008).
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS, Schoenknecht P, Torosjan Y et al. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann. Gen. Psychiatry5, 19 (2006).
   PubMedGoogle Scholar
• Schlosser RG, Nenadic I, Wagner G et al. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr. Res.89(1–3), 1–11 (2007).
   PubMed Web of Science ®Google Scholar
• Mitelman SA, Newmark RE, Torosjan Y et al. White matter fractional anisotropy and outcome in schizophrenia. Schizophr. Res.87(1–3), 138–159 (2006).
   PubMed Web of Science ®Google Scholar
• Agartz I, Andersson J, Skare S. Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport12, 2251–2254 (2001).
   PubMed Web of Science ®Google Scholar
• Ardekani B, Nierenberg J, Hoptman M, Javitt D, Lim K. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport14, 2025–2029 (2003).
   PubMed Web of Science ®Google Scholar
• Caan MW, Vermeer KA, Van Vliet LJ et al. Shaving diffusion tensor images in discriminant analysis: a study into schizophrenia. Med. Image Anal.10(6), 841–849 (2006).
   PubMed Web of Science ®Google Scholar
• Mori T, Ohnishi T, Hashimoto R et al. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res.154(2), 133–145 (2007).
   PubMed Web of Science ®Google Scholar
• Nestor PG, Kubicki M, Gurrera RJ et al. Neuropsychological correlates of diffusion tensor imaging in schizophrenia. Neuropsychology18(4), 629–637 (2004).
   PubMed Web of Science ®Google Scholar
• Shergill SS, Kanaan RA, Chitnis XA et al. A diffusion tensor imaging study of fasciculi in schizophrenia. Am. J. Psychiatry164(3), 467–473 (2007).
   PubMed Web of Science ®Google Scholar
• Hao Y, Liu Z, Jiang T et al. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport17(1), 23–26 (2006).
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Namiki C, Hirao K et al. Anterior and posterior cingulum abnormalities and their association with psychopathology in schizophrenia: a diffusion tensor imaging study. Schizophr. Res.95(1–3), 215–222 (2007).
   PubMed Web of Science ®Google Scholar
• Seal ML, Yucel M, Fornito A et al. Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity. Schizophr. Res.101(1–3), 106–110 (2008).
   PubMed Web of Science ®Google Scholar
• Burns J, Job D, Bastin M et al. Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br. J. Psychiatry182, 439–443 (2003).
   PubMed Web of Science ®Google Scholar
• Hoptman M, Ardekani B, Butler P, Nierenberg J, Javitt D, Lim K. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport15, 2467–2470 (2004).
   PubMed Web of Science ®Google Scholar
• Perez-Iglesias R, Tordesillas-Gutierrez D, Mcguire PK et al. White matter integrity and cognitive impairment in first-episode psychosis. Am. J. Psychiatry167(4), 451–458 (2010).
   PubMed Web of Science ®Google Scholar
• Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon DH, Pearlson GD. Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr. Res.98(1–3), 157–162 (2008).
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Ardekani BA, Ashtari M et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am. J. Psychiatry162(3), 602–605 (2005).
   PubMed Web of Science ®Google Scholar
• Kyriakopoulos M, Frangou S. Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr. Opin. Psychiatry22(2), 168–176 (2009).
   PubMed Web of Science ®Google Scholar
• Perez-Iglesias R, Tordesillas-Gutierrez D, Barker GJ et al. White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage49(1), 199–204 (2010).
   PubMed Web of Science ®Google Scholar
• Karlsgodt KH, Niendam TA, Bearden CE, Cannon TD. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol. Psychiatry66(6), 562–569 (2009).
   PubMed Web of Science ®Google Scholar
• Munoz Maniega S, Lymer GK, Bastin ME et al. A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr. Res.106(2–3), 132–139 (2008).
   PubMed Web of Science ®Google Scholar
• Hoptman MJ, Nierenberg J, Bertisch HC et al. A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophr. Res.106(2–3), 115–124 (2008).
   PubMed Web of Science ®Google Scholar
• Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr. Res.108(1–3), 3–10 (2009).
   PubMed Web of Science ®Google Scholar
• Jeong B, Wible CG, Hashimoto R, Kubicki M. Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia. Hum. Brain Mapp.30(12), 4138–4151 (2009).
   PubMed Web of Science ®Google Scholar
• Gusnard DA, Akbudak E, Shulman GL, Raichle ME. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc. Natl Acad. Sci. USA98(7), 4259–4264 (2001).
   PubMed Web of Science ®Google Scholar
• Raichle ME, Macleod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc. Natl Acad. Sci. USA98(2), 676–682 (2001).
   PubMed Web of Science ®Google Scholar
• Skudlarski P, Jagannathan K, Calhoun VD, Hampson M, Skudlarska BA, Pearlson G. Measuring brain connectivity: diffusion tensor imaging validates resting state temporal correlations. Neuroimage43(3), 554–561 (2008).
   PubMed Web of Science ®Google Scholar
• Greicius MD, Supekar K, Menon V, Dougherty RF. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex19(1), 72–78 (2009).
   PubMed Web of Science ®Google Scholar
• Teipel SJ, Bokde AL, Meindl T et al. White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage49(3), 2021–2032 (2010).
   PubMed Web of Science ®Google Scholar
• Skudlarski P, Jagannathan K, Anderson K et al. Brain connectivity is not only lower but different in schizophrenia: a combined anatomical and functional approach. Biol. Psychiatry68(1), 61–69 (2010).
   PubMed Web of Science ®Google Scholar
• Whitford TJ, Ford JM, Mathalon DH, Kubicki M, Shenton ME. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr. Bull. DOI: 10.1093/schbul/sbq105 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Whitford TJ, Mathalon DH, Shenton ME et al. Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia. Psychol. Med.41(5), 959–969 (2011).
   PubMed Web of Science ®Google Scholar
• Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatr. Res.17(4), 319–334 (1982).
   PubMed Web of Science ®Google Scholar
• Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol. Psychiatry59(10), 929–939 (2006).
   PubMed Web of Science ®Google Scholar
• Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull.35(3), 509–527 (2009).
   PubMed Web of Science ®Google Scholar
• Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr. Bull.4(4), 636–640 (1978).
   PubMed Web of Science ®Google Scholar
• Frith C. The Cognitive Neuropsychology of Schizophrenia. Lawrence Erlbaum Associates, Hove, UK (1992).
   Google Scholar
• Smieskova R, Fusar-Poli P, Allen P et al. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? – A systematic review. Curr. Pharm. Des.15(22), 2535–2549 (2009).
   PubMed Web of Science ®Google Scholar
• Vita A, De Peri L. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int. Rev. Psychiatry19(4), 429–436 (2007).
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson GD, Charles C et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry62(4), 361–370 (2005).
   PubMed Web of Science ®Google Scholar
• Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry68(2), 128–137 (2011).
   PubMed Web of Science ®Google Scholar
• Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology30(9), 1649–1661 (2005).
   PubMed Web of Science ®Google Scholar
• Wang HD, Dunnavant FD, Jarman T, Deutch AY. Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology29(7), 1230–1238 (2004).
   PubMed Web of Science ®Google Scholar
• Niu J, Mei F, Li N et al. Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem. Cell. Biol.88(4), 611–620 (2010).
   PubMedGoogle Scholar
• Wang H, Xu H, Niu J et al. Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain. Schizophr. Res.119(1–3), 164–174 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu H, Jiang W et al. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophr. Res.106(2–3), 182–191 (2008).
   PubMed Web of Science ®Google Scholar
• Xiao L, Xu H, Zhang Y et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol. Psychiatry13(7), 697–708 (2008).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Tatsumi K, Makinodan M et al. Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus. Neurochem. Int.57(5), 565–571 (2010).
   PubMed Web of Science ®Google Scholar
• Rosin C, Colombo S, Calver AA, Bates TE, Skaper SD. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation. Glia52(4), 336–343 (2005).
   PubMed Web of Science ®Google Scholar
• Konopaske GT, Dorph-Petersen KA, Sweet RA et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry63(8), 759–765 (2008).
   PubMed Web of Science ®Google Scholar
• Steiner J, Sarnyai Z, Westphal S et al. Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur. Arch. Psychiatry Clin. Neurosci. DOI: 10.1007/s00406-011-0197-3 (2011) (Epub ahead of print).
   Google Scholar
• Fernø J, Rader M, Vik-Mo A et al. Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics J.5(5), 298–304 (2005).
   PubMed Web of Science ®Google Scholar
• Narayan S, Kass KE, Thomas EA. Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. J. Neurosci. Res.85(4), 757–765 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas EA, George RC, Danielson PE et al. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol. Psychiatry8(12), 983–993, 950 (2003).
   PubMed Web of Science ®Google Scholar
• Thomas EA, Danielson PE, Nelson PA et al. Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J. Neurochem.76(3), 789–796 (2001).
   PubMed Web of Science ®Google Scholar
• Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med.39(11), 1763–1777 (2009).
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Lu PH, Nuechterlein KH et al. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr. Res.93(1–3), 13–22 (2007).
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Lu PH, Stewart SB et al. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr. Res.113(2–3), 322–331 (2009).
   PubMed Web of Science ®Google Scholar
• Christensen J, Holcomb J, Garver D. State-related changes in cerebral white matter may underlie psychosis exacerbation. Psychiatry Res. Neuroimaging30, 71–78 (2004).
   Google Scholar
• Garver DL, Holcomb JA, Christensen JD. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int. Neuropsychopharmacol.11(1), 49–61 (2008).
   PubMed Web of Science ®Google Scholar
• Girgis RR, Diwadkar VA, Nutche JJ, Sweeney JA, Keshavan MS, Hardan AY. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr. Res.82(1), 89–94 (2006).
   PubMed Web of Science ®Google Scholar
• Bartzokis G, Lu PH, Stewart SB et al. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr. Res.113(2–3), 322–331 (2009).
   PubMed Web of Science ®Google Scholar
• Orre K, Wennstrom M, Tingstrom A. Chronic lithium treatment decreases NG2 cell proliferation in rat dentate hilus, amygdala and corpus callosum. Prog. Neuropsychopharmacol. Biol. Psychiatry33(3), 503–510 (2009).
   PubMed Web of Science ®Google Scholar
• Dill J, Wang H, Zhou F, Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci.28(36), 8914–8928 (2008).
   PubMed Web of Science ®Google Scholar
• Macritchie KA, Lloyd AJ, Bastin ME et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br. J. Psychiatry196(1), 52–58 (2010).
   PubMed Web of Science ®Google Scholar
• Manning SM, Talos DM, Zhou C et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J. Neurosci.28(26), 6670–6678 (2008).
   PubMed Web of Science ®Google Scholar
• Krivoy A, Weizman A, Laor L, Hellinger N, Zemishlany Z, Fischel T. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study. Eur. Neuropsychopharmacol.18(2), 117–121 (2008).
   PubMed Web of Science ®Google Scholar
• Afshar H, Roohafza H, Mousavi G et al. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. J. Psychopharmacol.23(2), 157–162 (2009).
   PubMed Web of Science ®Google Scholar
• Skihar V, Silva C, Chojnacki A et al. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl Acad. Sci. USA106(42), 17992–17997 (2009).
   PubMed Web of Science ®Google Scholar
• Lavedan C, Volpi S, Polymeropoulos MH, Wolfgang CD. Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial. Pharmacogenomics9(3), 289–301 (2008).
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Ujike H, Fujiwara Y et al. Schizophrenic psychoses and the CNTF null mutation. Neuroreport9(6), 981–983 (1998).
   PubMed Web of Science ®Google Scholar
• Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl Acad. Sci. USA101(21), 8180–8185 (2004).
   PubMed Web of Science ®Google Scholar
• Kipnis J, Cardon M, Strous RD, Schwartz M. Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia? Trends Mol. Med.12(3), 107–112 (2006).
   PubMed Web of Science ®Google Scholar
• Bartzokis G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacol.27, 672–683 (2002).
   PubMed Web of Science ®Google Scholar
• Peters A, Sethares C. Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb. Cortex14(9), 995–1007 (2004).
   PubMed Web of Science ®Google Scholar
• Peters A. Structural changes in the normally aging cerebral cortex of primates. Prog. Brain Res.136, 455–465 (2002).
   PubMed Web of Science ®Google Scholar